...
首页> 外文期刊>Clinical investigation >Incentives and barriers to neurological clinical research participation
【24h】

Incentives and barriers to neurological clinical research participation

机译:神经科学临床研究参与的激励机制和障碍

获取原文
获取原文并翻译 | 示例

摘要

Background: Understanding barriers and incentives to neurological research participation may improve clinical trial enrollment. Results: Telephone-based focus groups were conducted with four neurological disorder patient groups (n = 22) and one caregiver group (n = 6). A total of 14 neurologists and neuro-surgeons participated in structured interviews. Topics discussed included identifying ways in which health information is gathered and attitudes toward participation in medical research. Interestingly, 86% of physicians interviewed have referred patients to clinical trials and 82% of patients expressed interest in clinical trials participation. Patients cited their primary physician as the best source of health-related information, including information about clinical trials. Barriers to patients and physicians regarding clinical trials participation included compensation. Patients expressed concern about increased visit frequency and required treatment changes. Conclusion: Patients are willing to participate in clinical trials and physicians are willing to refer patients for participation with appropriate compensation for their time and sensitivity to change in care.
机译:背景:了解神经系统研究参与的障碍和诱因可能会改善临床试验的招募人数。结果:以电话为基础的焦点小组进行了四个神经系统疾病患者组(n = 22)和一个护理人员组(n = 6)。共有14位神经科医生和神经外科医生参加了结构化访谈。讨论的主题包括确定收集健康信息的方式以及对参与医学研究的态度。有趣的是,接受采访的医师中有86%已将患者转诊至临床试验,而82%的患者表示有兴趣参加临床试验。患者将其主治医生视为健康相关信息(包括有关临床试验信息)的最佳来源。对患者和医生的临床试验参与障碍包括补偿。患者对增加就诊频率和需要改变治疗方法表示关注。结论:患者愿意参加临床试验,医生愿意为患者参加治疗,并对其时间和对护理变化的敏感性进行适当补偿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号